These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

489 related articles for article (PubMed ID: 27801706)

  • 21. The influence of genetic susceptibility and calcium plus vitamin D supplementation on fracture risk.
    Wang Y; Wactawski-Wende J; Sucheston-Campbell LE; Preus L; Hovey KM; Nie J; Jackson RD; Handelman SK; Nassir R; Crandall CJ; Ochs-Balcom HM
    Am J Clin Nutr; 2017 Apr; 105(4):970-979. PubMed ID: 28148500
    [No Abstract]   [Full Text] [Related]  

  • 22. Insights into the epidemiology of postmenopausal osteoporosis: the Women's Health Initiative.
    Jackson RD; Mysiw WJ
    Semin Reprod Med; 2014 Nov; 32(6):454-62. PubMed ID: 25321423
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hormone therapy and coronary heart disease: the role of time since menopause and age at hormone initiation.
    Grodstein F; Manson JE; Stampfer MJ
    J Womens Health (Larchmt); 2006; 15(1):35-44. PubMed ID: 16417416
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Calcium, vitamin D supplementation, and physical function in the Women's Health Initiative.
    Brunner RL; Cochrane B; Jackson RD; Larson J; Lewis C; Limacher M; Rosal M; Shumaker S; Wallace R;
    J Am Diet Assoc; 2008 Sep; 108(9):1472-9. PubMed ID: 18755319
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Calcium supplementation and fracture risk--recent findings from the women's health initiative study.
    Kruse H
    S D Med; 2006 May; 59(5):207-8. PubMed ID: 16729654
    [No Abstract]   [Full Text] [Related]  

  • 26. The role of hormone therapy and calcium plus vitamin D for reduction of bone loss and risk for fractures: lessons learned from the Women's Health Initiative.
    Jackson RD; Shidham S
    Curr Osteoporos Rep; 2007 Dec; 5(4):153-9. PubMed ID: 18430389
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Menopause and stroke and the effects of hormonal therapy.
    Lobo RA
    Climacteric; 2007 Oct; 10 Suppl 2():27-31. PubMed ID: 17882669
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Supplementation of vitamin D isolated or calcium-associated with bone remodeling and fracture risk in postmenopausal women without osteoporosis: A systematic review of randomized clinical trials.
    Reis AR; Santos RKF; Dos Santos CB; Santos BDC; de Carvalho GB; Brandão-Lima PN; de Oliveira E Silva AM; Pires LV
    Nutrition; 2023 Dec; 116():112151. PubMed ID: 37544189
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Osteoporosis in the Women's Health Initiative: Another Treatment Gap?
    Sattari M; Cauley JA; Garvan C; Johnson KC; LaMonte MJ; Li W; Limacher M; Manini T; Sarto GE; Sullivan SD; Wactawski-Wende J; Beyth RJ
    Am J Med; 2017 Aug; 130(8):937-948. PubMed ID: 28366425
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause.
    Rossouw JE; Prentice RL; Manson JE; Wu L; Barad D; Barnabei VM; Ko M; LaCroix AZ; Margolis KL; Stefanick ML
    JAMA; 2007 Apr; 297(13):1465-77. PubMed ID: 17405972
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fracture Rates and Bone Density Among Postmenopausal Veteran and Non-Veteran Women From the Women's Health Initiative.
    LaFleur J; Rillamas-Sun E; Colón-Emeric CS; Knippenberg KA; Ensrud KE; Gray SL; Cauley JA; LaCroix AZ
    Gerontologist; 2016 Feb; 56 Suppl 1(Suppl 1):S78-90. PubMed ID: 26768394
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vitamin D and calcium supplementation and one-year change in mammographic density in the women's health initiative calcium and vitamin D trial.
    Bertone-Johnson ER; McTiernan A; Thomson CA; Wactawski-Wende J; Aragaki AK; Rohan TE; Vitolins MZ; Tamimi RM; Johnson KC; Lane D; Rexrode KM; Peck JD; Chlebowski RT; Sarto G; Manson JE
    Cancer Epidemiol Biomarkers Prev; 2012 Mar; 21(3):462-73. PubMed ID: 22253296
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Concordance of Results from Randomized and Observational Analyses within the Same Study: A Re-Analysis of the Women's Health Initiative Limited-Access Dataset.
    Bolland MJ; Grey A; Gamble GD; Reid IR
    PLoS One; 2015; 10(10):e0139975. PubMed ID: 26440516
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vitamin A and retinol intakes and the risk of fractures among participants of the Women's Health Initiative Observational Study.
    Caire-Juvera G; Ritenbaugh C; Wactawski-Wende J; Snetselaar LG; Chen Z
    Am J Clin Nutr; 2009 Jan; 89(1):323-30. PubMed ID: 19056568
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recency and duration of postmenopausal hormone therapy: effects on bone mineral density and fracture risk in the National Osteoporosis Risk Assessment (NORA) study.
    Barrett-Connor E; Wehren LE; Siris ES; Miller P; Chen YT; Abbott TA; Berger ML; Santora AC; Sherwood LM
    Menopause; 2003; 10(5):412-9. PubMed ID: 14501602
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term oral bisphosphonate use in relation to fracture risk in postmenopausal women with breast cancer: findings from the Women's Health Initiative.
    Drieling RL; LaCroix AZ; Beresford SA; Boudreau DM; Kooperberg C; Chlebowski RT; Gass M; Crandall CJ; Womack CR; Heckbert SR
    Menopause; 2016 Nov; 23(11):1168-1175. PubMed ID: 27433859
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Postmenopausal hormone therapy and migraine headache.
    Misakian AL; Langer RD; Bensenor IM; Cook NR; Manson JE; Buring JE; Rexrode KM
    J Womens Health (Larchmt); 2003 Dec; 12(10):1027-36. PubMed ID: 14709191
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Calcium plus vitamin D supplementation and lung cancer incidence among postmenopausal women in the Women's Health Initiative.
    Tao MH; Dai Q; Chen S; Freudenheim JL; Rohan T; Wakelee H; Datta M; Wactawski-Wende J
    Lung Cancer; 2017 Aug; 110():42-47. PubMed ID: 28676217
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of pelvic organ prolapse and fractures in postmenopausal women: analysis of baseline data from the Women's Health Initiative Estrogen Plus Progestin trial.
    Pal L; Hailpern SM; Santoro NF; Freeman R; Barad D; Kipersztok S; Barnabei VM; Wassertheil-Smoller S
    Menopause; 2008; 15(1):59-66. PubMed ID: 18257143
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Health characteristics of women beginning postmenopausal hormone therapy: have they changed since the publication of the Women's Health Initiative?
    Fournier A; Fritel X; Panjo H; Zins M; Ringa V
    Menopause; 2014 Jul; 21(7):687-93. PubMed ID: 24378763
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.